Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare
Moleculin Biotech Inc. Operating Income 2020–2025
Moleculin Biotech Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Moleculin Biotech Inc. operating income for the quarter ending March 31, 2026 was -7.9 M, a 32.49% increase year-over-year.
- Moleculin Biotech Inc. operating income for the twelve months ending March 31, 2026 was -27.0 M.
- Moleculin Biotech Inc. annual operating income for 2025 was -25.1 M, a 5.77% decrease from 2024.
- Moleculin Biotech Inc. annual operating income for 2024 was -26.6 M, a 10.09% decrease from 2023.
- Moleculin Biotech Inc. annual operating income for 2023 was -29.6 M, a 3.29% decrease from 2022.
- Moleculin Biotech Inc. annual operating income for 2022 was -30.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Moleculin Biotech Inc. Operating Income — FAQ
Moleculin Biotech Inc. (MBRX) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Moleculin Biotech Inc.'s operating income?
Moleculin Biotech Inc. (MBRX) reported operating income of -$25M for fiscal 2025.
Where can I see MBRX's operating income history?
The chart and table above show Moleculin Biotech Inc.'s operating income by year and by quarter, including the growth rate.